Host: Matt Birnholz, MD Guest: Kevin Fussell, MD Up to one in 10 patients with asthma have severe disease, and of those patients, up to 1.3 million have severe uncontrolled asthma.1-3 Since severe asthma has been associated with reduced lung function and poor outcomes.4,5 Dr Kevin Fussell is here to talk about how a treatment option may help patients with severe eosinophilic asthma as well as how we can use telemedicine to help manage and diagnose them. Chung KF, Wenzel SE, Brozek JL, et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J. 2014;43(2):343-373. Hankin CS, Bronstone A, Wang Z, Small MB, Buck P. Estimated prevalence and economic burden of severe, uncontrolled asthma in the United States. J Allergy Clin Immunol. 2013;131(2):AB126. Global Initiative for Asthma. Global strategy for asthma management and prevention. Updated 2020. Available from: https://ginasthma.org/wp-content/uploads/2020/06/GINA-2020-report_20_06_04-1-wms.pdf. Accessed August 22, 2020. Newby C, Agbetile J, Hargadon, B, et al. Lung function decline and variable airway inflammatory pattern: longitudinal analysis of severe asthma. J Allergy Clin Immunol. 2014;134(2):287-294. Global Initiative for Asthma. Difficult-to-treat and severe asthma in adolescent and adult patients 2019. Available from:https://ginasthma.org/wp-content/uploads/2019/04/GINA-Severe-asthma-Pocket-Guide-v2.0-wms-1.pdf. Accessed November 1, 2020. ©2020 AstraZeneca. All rights reserved. US-34513 Last Updated 11/20 ...

Hot Topics in Allergy

Integrating Telemedicine to Help Diagnose & Manage Severe Eosinophilic Asthma

Host: Jennifer Caudle, DO Guest: Maria Pasioti Food allergy trials help us stay on the cutting edge by studying the latest treatment advances, but are we consistent in the terminology we use and even in the way we apply these findings to clinical practice? To find out, Dr. Jennifer Caudle welcomes Dr. Maria Pasioti, who discusses the design, endpoints, and real-world implications of food allergy trials. 

The Design, Endpoints, & Real-World Implications of Food Allergy Trials

Guest: Maria Pasioti Here to give us a glimpse into the prevalence and impact of IgE-mediated food allergies in the EU is Dr. Maria Pasioti, an allergist at Laiko Hospital in Athens, Greece.

A Look at the Increasing Prevalence of Food Allergies in the EU

Host: Jennifer Caudle, DO Guest: Anne Ellis, MD Guest: George DuToit, MD Managing a food allergy can be difficult for both physicians and patients, which is why advocacy groups are working to advance the interests of this community and develop guidelines for healthcare professionals. To find out more, Dr. Jennifer Caudle is joined by Drs. Anne Ellis and George DuToit, who discuss their opinions and go into detail about how physicians can help patients living with a food allergy.

How Advocacy Groups Are Enhancing Food Allergy Care

Host: Jennifer Caudle, DO Guest: Bruce Lanser, MD Guest: Drew Bird, MD Clinical trials are an important part of food allergy research, but there are some pretty big differences in the language that’s used to define primary endpoints and reported outcomes—not only here, but also abroad. Joining Dr. Jennifer Caudle to interpret the language that’s used in food allergy research and the implications of these different dialects are Drs. Drew Bird and Bruce Lanser. 

Translating the Language of Food Allergy Research

Host: Mario R. Nacinovich, Jr., MSc Guest: Jonathan Spergel, MD, PhD Get a bird’s-eye view of how oral immunotherapy (OIT) is developing in different countries with Dr. Mario Nacinovich and Dr. Jonathan Spergel, who also discusses the reasoning behind this strategy and when we should use this treatment option for our patients with food allergies. 

Looking Back, Moving Forward: OIT’s Origins & Emerging Insights

Host: Amy Mackey, MD Guest: Jay Lieberman, MD Guest: Alan Goldsobel, MD When it comes to managing patients with food allergy, what team members should contribute within your practice? To find out, Dr. Amy Mackey speaks with Drs. Jay Lieberman and Alan Goldsobel who discuss their food allergy care teams along with how they overcome common obstacles.

Maximizing Team Effectiveness in Food Allergy Care

Guest: Jay Lieberman, MD Food challenges can be done in a few different ways, and here to walk us through two types that are commonly used in research and clinical settings is Dr. Jay Lieberman, Associate Professor in the Department of Pediatrics at the University of Tennessee Health Science Center.

Defining 2 Types of Oral Food Challenges

Guest: Jay Lieberman, MD As oral immunotherapy for food allergy continues to gain traction in clinical trials, Dr. Jay Lieberman shares four key takeaways regarding its side effects, whether it should be viewed as a cure, how it could potentially change a patient’s lifestyle, and ultimately, if it’s the answer for every patient with a food allergy.

4 Things to Know About Oral Immunotherapy for Food Allergy

Host: Todd Mahr, MD Guest: Warner Carr, MD What phases does the FDA use to approve a new medication, and why does this process take several years? Why must the active and excipient components of the medication, as well as the device, complete all of the testing phases? Dr. Warner Carr, allergist at Allergy and Asthma Associates in Mission Viejo, California, shares insight from his role as a new drug reviewer at the FDA. How do physicians play a vital role in the drug-approval process by providing clinical feedback to the FDA? Dr. Todd Mahr hosts.

The FDA Drug-Approval Process for Allergy Products

Host: Ketan Sheth, MD, MBA Guest: Carlos Camargo, MD, DrPH, MPH What's the best strategy for managing patients with chronic asthma, and how can physicians create an action plan with their patients to treat an asthma exacerbation? Host Dr. Ketan Sheth reviews recent guideline recommendations for preventing asthma exacerbations with Dr. Carlos Camargo, associate professor of medicine and epidemiology at Harvard Medical School. How are acute and chronic management of asthma different?

Preventing Asthma Exacerbations

Host: Ketan Sheth, MD, MBA Guest: William Lumry, MD Hereditary angioedema is relatively rare and is often misdiagnosed as an allergic reaction to medication or food. What symptoms are helpful differentiating points for making an accurate hereditary angioedema diagnosis? Dr. William Lumry, clinical professor of internal medicine at the University of Texas Southwestern Medical School, outlines the types of hereditary angioedema, factors which can contribute to an acute attack, and therapies to prevent or treat patients with this condition. Dr. Ketan Sheth hosts.

Hereditary Angioedema

This series highlights expert perspectives, key studies, and breaking news from a diverse portfolio of allergy, asthma, and immunology topics. Hosted by clinical allergists Dr. Todd Mahr and Dr. Ketan Sheth, and produced in partnership with the American College of Asthma, Allergy, and Immunology, Hot Topics in Allergy is America's go-to resource for accurate and timely AAI education.

hubhopper

Hot Topics in Allergy

hubhopper